Health Canada approval of low-dose colchicine for cardiovascular disease based on the COLCOT study

NEXT STORY
Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply
PREV STORY
Insights on the Magnetic Resonance Imaging Systems Global Market to 2026 – Increasing Global Population is Driving Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

First patient dosed in avdoralimab Phase II clinical trial in COVID-19 patients with severe pneumonia

author_avatar
NASDAQ Market News

Artelo Biosciences Receives Ethics Approval to Commence its Cancer Appetite Recovery Phase I/II Clinical Study (CAReS) of ART27.13 for the Treatment of Cancer-Related Anorexia

author_avatar
NASDAQ Market News

Precision Nutrition Coaching to Open Registration for January 2021 Online Program, Helping a New Wave of Clients Transform Their Health with a Habits-Based Approach

author_avatar
NASDAQ Market News